Reckitt Benckiser Group Stock News

The British consumer goods company, which sells brands including Enfamil formula, is reviewing the business globally and has been informally gauging buyer interest in the operations, according to the people.

i

Reckitt Benckiser Group Plcs plan to review its infant nutrition unit and weigh options including a potential sale boosted the shares of the maker of Lysol.

Volatility is back on Wall Street, with tech suffering its worst month since 2008. No one knows how long or deep the 2022 correction will be, but prudent risk-management, not market timing is your bes

The iconic E45 skincare brand is set to be sold to Swedish pharmaceutical firm Karo Pharma for £200million, its Slough-based owner Reckitt Benckiser Group said on Friday.

SLOUGH (dpa-AFX) - Reckitt Benckiser Group PLC (RBGPF.PK, RB.L) has entered into an agreement for the proposed sale of its E45 brand and related sub-brands to Karo Pharma for an implied enterprise

(RTTNews) - Reckitt Benckiser Group PLC (RBGPF.PK, RB.L) has entered into an agreement for the proposed sale of its E45 brand and related sub-brands to Karo Pharma for an implied enterprise value of 200 million pounds. The proposed sale is expected to close in the second quarter of 2022. Laxman Narasimhan, CEO of Reckitt, said: "As we shift

Reckitt Benckiser Group (LON:RKT) had its price target boosted by Barclays from GBX 8,900 ($117.58) to GBX 9,400 ($124.19) in a research note published on Tuesday, Analyst Price Targets reports. The firm currently has an overweight rating on the stock. RKT has been the topic of several other reports. JPMorgan Chase & Co. reiterated an []

Reckitt Benckiser said on Friday it will sell its E45 skincare brand and related sub-brands to Karo Pharma for 200 million pounds ($267.98 million), as the British consumer goods maker shifts its focu

Reckitt Benckiser Group PLC (LSE:RKT, ETR:3RB) said it agreed to sell its E45 skincare business to Karo Pharma for an implied enterprise value of £200mln as part of its drive for higher growth. The b

Reckitt Benckiser Group (LON:RB) has been given a GBX 9,400 ($124.19) price target by equities researchers at Barclays in a research note issued on Tuesday, Borsen Zeitung reports. Several other equities research analysts also recently issued reports on the stock. Berenberg Bank set a GBX 7,170 ($94.73) price objective on shares of Reckitt Benckiser Group […]

Reckitt Benckiser Group plc (LON:RB) has been given a consensus recommendation of Strong Buy by the twelve research firms that are presently covering the company, MarketBeat Ratings reports. One analyst has rated the stock with a buy recommendation and one has given a strong buy recommendation to the company. The average twelve-month price objective among []

JPMorgan Chase & Co. reissued their overweight rating on shares of Reckitt Benckiser Group (LON:RKT) in a research note issued to investors on Thursday, Price Targets.com reports. The brokerage currently has a GBX 8,500 ($112.33) price target on the stock. RKT has been the topic of several other research reports. Berenberg Bank lowered their target []

Reckitt Benckiser Group (LON:RKT)s stock had its overweight rating reiterated by JPMorgan Chase & Co. in a note issued to investors on Thursday, Analyst Ratings Network reports. They presently have a GBX 8,500 ($112.33) price target on the stock. JPMorgan Chase & Co.s target price would indicate a potential upside of 36.44% from the companys []

The FTSE 100 erased earlier losses to close 0.1% higher, as large dollar earners including Diageo, Unilever, British American Tobacco and Reckitt Benckiser benefited from the sterling falling. Limiting gains, shares of HSBC shed 0.6% after the UK''s financial regulator said it had fined the bank 63.95 million pounds ($85.16 million) for failings in its anti-money laundering processes.